EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Residual microglia following short‐term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy

Maheedhar Kodali, Leelavathi N Madhu, Yogish Somayaji, Sahithi Attaluri, Charles Huard, Prashanta Kumar Panda, Goutham Shankar, Shama Rao, Bing Shuai, Jenny J Gonzalez, Chris Oake, Catherine Hering und 3 weitere

Aging Cell · 2025

DOI: 10.1111/acel.14398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Maheedhar Kodali und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Regenerative Medicine, Department of Cell Biology and Genetics, Texas A&M University Health Science Center School of Medicine, College …. Hauptthemen laut MEDLINE: Microglia, TOR Serine-Threonine Kinases, NLR Family, Pyrin Domain-Containing 3 Protein, Autophagy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While moderately activated microglia in Alzheimer's disease (AD) are pivotal in clearing amyloid beta (Aβ), hyperactivated microglia perpetuate neuroinflammation. Prior investigations reported that the elimination of ~80% of microglia through inhibition of the colony‐stimulating factor 1 receptor (CSF1R) during the advanced stage of neuroinflammation in 5xFamilial AD (5xFAD) mice mitigates synapse loss and neurodegeneration. Furthermore, prolonged CSF1R inhibition diminished the development of parenchymal plaques. Nonetheless, the effects of short‐term CSF1R inhibition during the early stages of neuroinflammation on residual microglia are unknown. Therefore, we investigated the effects of 10‐day CSF1R inhibition using PLX5622 in three‐month‐old female 5xFAD mice, a stage characterized by the onset of neuroinflammation and minimal Aβ plaques. We observed ~65% microglia depletion in the hippocampus and cerebral cortex. The leftover microglia displayed a noninflammatory phenotype with reduced NOD‐, LRR‐, and pyrin domain‐containing protein 3 (NLRP3) inflammasome complexes. Moreover, plaque‐associated microglia were reduced with diminished Clec7a expression. Additionally, phosphorylated S6 ribosomal protein and the protein sequestosome 1 analysis suggested reduced mechanistic targets of rapamycin (mTOR) signaling and autophagy in microglia and neurons within the hippocampus and cerebral cortex. Biochemical assays validated the inhibition of NLRP3 inflammasome activation, decreased mTOR signaling in the hippocampus and cerebral cortex, and enhanced autophagy in the hippocampus. However, short‐term CSF1R inhibition did not influence Aβ plaques, soluble Aβ‐42 levels, astrocyte hypertrophy, or hippocampal neurogenesis. Thus, short‐term CSF1R inhibition during the early stages of neuroinflammation in 5xFAD mice promotes the retention of homeostatic microglia with diminished inflammasome activation and mTOR signaling, alongside increased autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaTOR Serine-Threonine KinasesNLR Family, Pyrin Domain-Containing 3 ProteinAutophagyInflammasomesAlzheimer DiseaseAnimalsMiceSignal TransductionFemaleMice, TransgenicDisease Models, AnimalReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAmyloid beta-PeptidesOrganic Chemicals

Stichwörter der Autor:innen

Alzheimer's diseaseactivated microgliaamyloid‐beta plaquesautophagychronic neuroinflammationhippocampal neurogenesisinflammasomesmTOR signaling

Substanzen

TOR Serine-Threonine KinasesNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesPLX5622mTOR protein, mouseNlrp3 protein, mouseReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAmyloid beta-PeptidesCsf1r protein, mouseOrganic Chemicals

Autor:innen und Institutionen

  • Institute for Regenerative Medicine, Department of Cell Biology and Genetics, Texas A&M University Health Science Center School of Medicine, College Station, Texas, USA.

ORCID-Profile: Ashok K Shetty

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute on Aging

Zitieren

APA

Kodali, M., Madhu, L. N., Somayaji, Y., Attaluri, S., Huard, C., Panda, P. K., Shankar, G., Rao, S., Shuai, B., Gonzalez, J. J., Oake, C., Hering, C., Babu, R. S., Kotian, S., & Shetty, A. K. (2025). Residual microglia following short‐term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy. Aging Cell. https://doi.org/10.1111/acel.14398

Vancouver

Kodali M, Madhu LN, Somayaji Y, Attaluri S, Huard C, Panda PK, et al. Residual microglia following short‐term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy. Aging Cell. 2025. doi:10.1111/acel.14398

BibTeX
@article{Kodali2025,
  author = {Kodali, Maheedhar and Madhu, Leelavathi N and Somayaji, Yogish and Attaluri, Sahithi and Huard, Charles and Panda, Prashanta Kumar and Shankar, Goutham and Rao, Shama and Shuai, Bing and Gonzalez, Jenny J and Oake, Chris and Hering, Catherine and Babu, Roshni Sara and Kotian, Sanya and Shetty, Ashok K},
  title = {Residual microglia following short‐term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy},
  journal = {Aging Cell},
  year = {2025},
  doi = {10.1111/acel.14398}
}
Kostenlos starten →